ThomasUldrickJr.MD

Deputy Head, Global Oncology

Dr. Uldrick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1100 Fairview Ave N
Mail Stop M1-B140
Seattle, WA 98109
Phone+1 206-667-7485

Fax+1 206-667-1965

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2005 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
State University of New York Downstate Medical Center College of MedicineClass of 2002

PubMed

Journal Articles

Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNA
Ramya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences
International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease
Aaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood

Abstracts/Posters

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients...
Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R2) in Primary Effusion Lymphoma in Patients with or without HIV
Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Phase I study of pembrolizumab in people with HIV and cancer.
2019 ASCO Annual Meeting - 6/1/2019
Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early MortalityClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Cancer Immunotherapy Flushes HIV Out of HidingFebruary 9th, 2022
Cancer Drug Flushes Out Latent HIV, Exciting New Study FindsJanuary 28th, 2022
Anti-Cancer Drug Can Flush Out HIV Hiding in Cells, Study SuggestsJanuary 27th, 2022
Join now to see all